Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Immunological Medicines for Pigs

Immunological veterinary medicinal products, including vaccines, are authorised for pigs.

Search results 76 to 85 from a total of 85

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

Zylexis

Paramunisierung, Stimulierung unspezifischer Immunmechanismen

Zoetis Deutschland GmbH

PEI.V.02388.01.1 05.11.2001 Hund, Katze, Pferd, Rind, Schwein

Aftopur DOE

Maul- und Klauenseuche

Boehringer Ingelheim Vetmedica GmbH

BFAV-B 367 17.12.2003 Rind, Schaf, Ziege, Schwein

Porcilis Lawsonia ID

Lawsonia intracellularis-Infektion

Intervet Deutschland GmbH

PEI.V.12022.01.1 04.01.2021 Schwein

Covexin 8

Enterotoxämie,
Rauschbrand,
Pararauschbrand,
Deutsche Bradsot,
Tetanus,
Infektiöse Hämoglobinurie

Zoetis Deutschland GmbH

A263/79 24.10.2005 Rind, Schaf, Schwein

Enteroporc Coli AC

E. coli-Infektion, Clostridien-Infektion

CEVA Santé Animale

EU/2/20/262/001-004 09.12.2020 Schwein

EPAR: Enteroporc Coli AC

PESTIPORC ORAL

Klassische Schweinepest

Ceva Tiergesundheit GmbH

FLI-B 363 23.02.2005 Schwein

BIOSUIS Salm

Salmonellen-Infektion

Bioveta, a.s., Tschechien

PEI.V.11984.01.1 23.08.2019 Schwein

Pestiffa CL

Klassische Schweinepest

Boehringer Ingelheim Vetmedica GmbH

ESP-L 4/84 09.12.2019 Schwein

PESTIPORC

Klassische Schweinepest

Ceva Tiergesundheit GmbH

ESP-L 1/91 10.10.2008 Schwein

Aftovaxpur DOE

Maul- und Klauenseuche

Boehringer Ingelheim Vetmedica GmbH

EU/2/13/153/001-850 15.07.2013 Rind, Schaf, Schwein

EPAR: Aftovaxpur DOE

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 528 in BAnz AT 25.04.2025 B4.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 25.04.2025